Modern methods of phase 1 clinical trial design

Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial

Polygenic risk scores for breast cancer: ready or not?

Modulation of anti-tumour immunity using CDK4/6 inhibitors

Brain metastases developed from HER2 positive and triple negative breast cancer

Single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity

Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in advanced breast cancer

SABCS 2018: Highlights in breast cancer treatment

Prognostic value of circulating tumour-cell count in metastatic breast cancer patients

Accelerated partial breast Irradiation vs whole breast irradiation to control ipsilateral breast tumour recurrence

Low-dose tamoxifen as effective as higher doses for breast cancer patients

Multiple myeloma highlights and more from ASH 2018